Thursday, September 1, 2016

BRIEF-Biogen's Aducanumab granted FDA fast track designation

* Biogen's investigational alzheimer's disease treatment

Aducanumab granted FDA fast track designation

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)